Navigation Links
DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco
Date:3/1/2010

ropean Sales, at Booth 72 to see how DATATRAK ONE™ provides a singular vision for the product and service delivery of all your clinical trial needs. Interested parties may also schedule a personal demonstration during the show by sending an email request to martijn.princen@datatrak.net.

About DIA Europe.

DIA's Annual EuroMeeting is the largest event of its kind in Europe, attracting more than 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry, contract service organizations, academic research centers, regulatory agencies, health ministries, patient organizations and trade associations. The event will host more than 350 speakers and 250 exhibitors. For more information on the 22nd Annual EuroMeeting, please see http://www.diahome.org.

About DATATRAK International, Inc.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv
2. DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management
3. DATATRAK International, Inc. Announces Year-End Backlog
4. DATATRAK Signs Five-Year Registry Study
5. DATATRAKs eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM)
6. PFC Pharma Joins DATATRAKs CRO Connect Program
7. DATATRAK Signs 6 Year Study with New Device Client
8. DATATRAK to Present at 2009 SCDM Annual Conference
9. DATATRAK eClinical(TM) Supports Multifaceted Studies
10. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
11. European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 The American Association for ... Maryland , announced today the filing of ... Washington, D.C. , asking that the scheduled July ... durable medical equipment (DME) be stopped because of serious licensing ... and Human Services (HHS) Secretary Kathleen Sebelius ...
(Date:6/19/2013)... , June 19, 2013 ... Philips under de kommande tre åren kommer att ... påskynda övergången till cirkulär ekonomi. Efter ... Kingfisher och National Grid, kommer Philips att ansluta ... inom cirkulär ekonomi i sin egen verksamhet och ...
(Date:6/19/2013)... , June 19, 2013  Finesse Solutions, Inc, ... life sciences process applications, announced the launch of ... upstream cell culture and fermentation.  The 3L glass ... family of Finesse bioreactors and are designed to ... They are fully compatible with all Finesse G3Lab ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... TARRYTOWN, N.Y. and BERLIN, April 8, 2011 ... and Bayer HealthCare today announced that they have initiated ... the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic ... certain eye diseases, in the treatment of Diabetic Macular ...
... Texas, April 7, 2011 Assured Pharmacy (APHY: pinksheets), ... more than 3,000 sufferers of chronic pain, has filed ... to effect a 1-for-180 reverse stock split of the ... reverse stock split in the number of issued and ...
Cached Medicine Technology:Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 2Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 3Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 4Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 5Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 6Assured Pharmacy Announces Reverse Stock Split 2Assured Pharmacy Announces Reverse Stock Split 3
(Date:6/19/2013)... June 19, 2013 Daily Gossip issued a ... training method will be published on their website at ... the article to inform readers about the information they will ... by reporters working at Daily Gossip, the article is a ... , Hiller has understood during the vast research he ...
(Date:6/19/2013)... June 19, 2013 Researchers from the ... demonstrated several new studies at ENDO 2013, The ... June 15-18 in San Francisco.     , Mount Sinai researchers ... the role of prostastic acid phosphatase (PAP) in Prostate ... stimulate the thyroid gland; revealed the prevalence of primary ...
(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...
(Date:6/19/2013)... CCA , America's leader in ... to Vice President, Health Services, effective June 8, 2013. ... Services for CCA. He will replace the retiring ... privilege to lead CCA's dedicated team of health care ... society and our partners as we provide effective care ...
(Date:6/19/2013)... Carlsbad, CA (PRWEB) June 19, 2013 ... , DHSc, DC, MS, explains why such seemingly minor ... anxiety, or concussions are vital red flags. They indicate ... risk for multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and ... , released in June 2013 by Elephant Press is ...
Breaking Medicine News(10 mins):Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... revenue of $21.9 million versus $23.8 million ... in the same quarter last year. - On target to ... Supplement ... (Nasdaq: NAII ), a leading,formulator, manufacturer and marketer of customized nutritional,supplements, today ...
... patients are seeing rectal cancer specialists at similar rates, ... or radiation therapy, according to a new study from ... study found blacks were 23 percent less likely to ... likely to receive radiation therapy than whites. , Although ...
... CT for false positives, study found , , TUESDAY, May 13 ... head and neck cancer may not boost a patient,s odds ... disease, new findings suggest. , Positron emission tomography with a ... commonly used to check whether head and neck squamous cell ...
... (Nasdaq: UAHC ), which owns and provides ... in,Tennessee, today announced financial results for its third ... 82 percent to $8.3 million for the third ... of $4.6 million for,the third quarter of the ...
... IRIDEX,Corporation (Nasdaq: IRIX ) today reported financial results for ... for the first quarter of 2008 was $11.5 million, an ... of 2007. The,Company,s net loss was $0.9 million or $0.10 ... a net loss of $4.9 million or $0.61 per,diluted share ...
... Alternatives Ongoing; Company Prepares for, Potential 2008 Launch of MOXATAG; Keflex ... ... in Quarter, GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, ... commercializing novel anti-infective products, today,announced financial and operational results for the ...
Cached Medicine News:Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 2Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 3Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 4Health News:Natural Alternatives International, Inc. Announces Third Quarter Results 5Health News:Blacks not receiving chemotherapy for rectal cancer, despite seeing cancer specialists 2Health News:High-Tech Imaging No Better for Diagnosing Head/Neck Cancers 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13
Each handle is designed to fit a specific trephine size....
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Medicine Products: